Boxer Capital, LLC - PTC THERAPEUTICS INC ownership

PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 134 filers reported holding PTC THERAPEUTICS INC in Q3 2017. The put-call ratio across all filers is 2.52 and the average weighting 0.3%.

Quarter-by-quarter ownership
Boxer Capital, LLC ownership history of PTC THERAPEUTICS INC
ValueSharesWeighting
Q3 2019$33,820,000
-24.8%
1,000,0000.0%2.45%
-36.6%
Q2 2019$45,000,000
+19.6%
1,000,0000.0%3.87%
-11.1%
Q1 2019$37,640,000
-49.1%
1,000,000
-53.6%
4.35%
-52.4%
Q4 2018$73,960,000
-27.0%
2,155,0000.0%9.14%
-18.7%
Q3 2018$101,285,000
+58.0%
2,155,000
+13.4%
11.24%
+54.9%
Q2 2018$64,087,000
-8.7%
1,900,000
-26.9%
7.26%
-3.1%
Q1 2018$70,174,000
+140.4%
2,600,000
+48.6%
7.49%
+40.4%
Q4 2017$29,190,000
+16.7%
1,750,000
+40.0%
5.34%
-6.3%
Q3 2017$25,013,000
-19.7%
1,250,000
-26.5%
5.69%
-23.2%
Q2 2017$31,161,000
+111.1%
1,700,000
+13.3%
7.41%
+129.8%
Q1 2017$14,760,0001,500,0003.22%
Other shareholders
PTC THERAPEUTICS INC shareholders Q3 2017
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 1,750,000$84,053,0007.32%
RTW INVESTMENTS, LP 3,832,480$184,074,0006.94%
Burrage Capital Management LLC 195,725$9,401,0006.30%
Asymmetry Capital Management, L.P. 55,408$2,661,0004.77%
SECTORAL ASSET MANAGEMENT INC 328,738$15,789,0002.36%
ARMISTICE CAPITAL, LLC 758,000$36,407,0002.10%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 114,000$5,470,0001.97%
Opaleye Management Inc. 191,000$9,174,0001.80%
Sofinnova Investments, Inc. 517,092$24,836,0001.79%
Chubb Ltd 8,180$393,0001.68%
View complete list of PTC THERAPEUTICS INC shareholders